✦ LIBER ✦

Secondary Angiosarcoma After Breast-conserving Therapy Treated With Hyperfractionated Radiation Therapy With a Median Follow-up of 6.7 Years

✍ Scribed by Linne, T.; Morris, C.G.; Mendenhall, N.P.

Book ID: 122515899
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 52 KB
Volume: 84
Category: Article
ISSN: 0360-3016
DOI: 10.1016/j.ijrobp.2012.07.617

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Interim Analysis of 354 Breast Cancer Pa

Interim Analysis of 354 Breast Cancer Patients Randomly Treated With Hyperfractionated or Conventional Fractionated Radiation Therapy After Breast-Conserving Surgery

✍ Li, S.; Wang, S.; Song, Y.; Wang, W.; Liu, X.; Ren, H.; Fang, H.; Li, Y. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 52 KB

The value of follow-up of patients with

The value of follow-up of patients with early breast cancer treated with conservative surgery and radiation therapy

✍ M. Grogan; A. Rangan; V. Gebski; J. Boyages 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 116 KB

Neoadjuvant therapy for breast cancer ha

Neoadjuvant therapy for breast cancer has no benefits on overall survival or on the mastectomy rate in routine clinical practice. A population-based study with a median follow-up of 11 years using propensity score matching

✍ I. Le Ray; S. Dabakuyo; G. Crehange; M. Bardou; L. Arnould; J. Fraisse; P. Fumol 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 496 KB

Excellent therapeutic efficacy and minim

Excellent therapeutic efficacy and minimal late neurotoxicity in children treated with 18 grays of cranial radiation therapy for high-risk acute lymphoblastic leukemia : A 7-year follow-up study of the dana-farber cancer institute consortium protocol 87-01

✍ Deborah P. Waber; Brenda L. Shapiro; Sarah C. Carpentieri; Richard D. Gelber; Gu 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB 👁 3 views

## Background: In the current study, the authors evaluated late neuropsychologic effects 7 years after diagnosis and the long-term survival in a cohort of patients treated for high-risk childhood acute lymphoblastic leukemia (all) with cranial radiation therapy. efficacy and toxicity were evaluated